KRMD
KORU Medical Systems, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$3.25
+0.93%Year over year
Reported trailing growth
- Revenue
- +22.4%
- EBITDA
- +73.9%
- EBIT
- +65.9%
- EPS
- +62.0%
- Free cash flow
- +112.0%
- Operating cash flow
- +303.9%
Forward estimates
Based on analyst estimates
- Revenue
- +15.8%
- EBITDA
- +154.3%
- EPS
- +74.0%
Three-year CAGR
- Revenue
- +13.8%
- EBITDA
- +65.9%
- EBIT
- +53.9%
- Net income
- +56.5%
- EPS
- +56.1%
- Free cash flow
- +70.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026